These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 24912680

  • 1. Cyclin D1 and C/EBPβ LAP1 operate in a common pathway to promote mammary epithelial cell differentiation.
    Liu Q, Boudot A, Ni J, Hennessey T, Beauparlant SL, Rajabi HN, Zahnow C, Ewen ME.
    Mol Cell Biol; 2014 Aug; 34(16):3168-79. PubMed ID: 24912680
    [Abstract] [Full Text] [Related]

  • 2. Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
    Milde-Langosch K, Löning T, Bamberger AM.
    Breast Cancer Res Treat; 2003 May; 79(2):175-85. PubMed ID: 12825852
    [Abstract] [Full Text] [Related]

  • 3. Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells.
    Dearth LR, Hutt J, Sattler A, Gigliotti A, DeWille J.
    J Cell Biochem; 2001 May; 82(3):357-70. PubMed ID: 11500913
    [Abstract] [Full Text] [Related]

  • 4. Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells.
    Baldwin BR, Timchenko NA, Zahnow CA.
    Mol Cell Biol; 2004 May; 24(9):3682-91. PubMed ID: 15082764
    [Abstract] [Full Text] [Related]

  • 5. LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis.
    Li H, Baldwin BR, Zahnow CA.
    Mol Cancer; 2011 Aug 19; 10():100. PubMed ID: 21854628
    [Abstract] [Full Text] [Related]

  • 6. Characterization of C/EBPbeta isoforms in normal versus neoplastic mammary epithelial cells.
    Eaton EM, Hanlon M, Bundy L, Sealy L.
    J Cell Physiol; 2001 Oct 19; 189(1):91-105. PubMed ID: 11573208
    [Abstract] [Full Text] [Related]

  • 7. Cell cycle defects contribute to a block in hormone-induced mammary gland proliferation in CCAAT/enhancer-binding protein (C/EBPbeta)-null mice.
    Grimm SL, Contreras A, Barcellos-Hoff MH, Rosen JM.
    J Biol Chem; 2005 Oct 28; 280(43):36301-9. PubMed ID: 16120603
    [Abstract] [Full Text] [Related]

  • 8. CCAAT/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology.
    Gutsch R, Kandemir JD, Pietsch D, Cappello C, Meyer J, Simanowski K, Huber R, Brand K.
    J Biol Chem; 2011 Jul 01; 286(26):22716-29. PubMed ID: 21558273
    [Abstract] [Full Text] [Related]

  • 9. C/EBPbeta-2 confers EGF-independent growth and disrupts the normal acinar architecture of human mammary epithelial cells.
    Bundy L, Wells S, Sealy L.
    Mol Cancer; 2005 Dec 21; 4():43. PubMed ID: 16371159
    [Abstract] [Full Text] [Related]

  • 10. CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture.
    Bundy LM, Sealy L.
    Oncogene; 2003 Feb 13; 22(6):869-83. PubMed ID: 12584567
    [Abstract] [Full Text] [Related]

  • 11. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer.
    Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS, Zahnow CA, Patterson N, Golub TR, Ewen ME.
    Cell; 2003 Aug 08; 114(3):323-34. PubMed ID: 12914697
    [Abstract] [Full Text] [Related]

  • 12. A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation.
    Zahnow CA, Cardiff RD, Laucirica R, Medina D, Rosen JM.
    Cancer Res; 2001 Jan 01; 61(1):261-9. PubMed ID: 11196172
    [Abstract] [Full Text] [Related]

  • 13. CCAAT/enhancer binding protein beta (C/EBPβ) isoform balance as a regulator of epithelial-mesenchymal transition in mouse mammary epithelial cells.
    Miura Y, Hagiwara N, Radisky DC, Hirai Y.
    Exp Cell Res; 2014 Sep 10; 327(1):146-55. PubMed ID: 24881817
    [Abstract] [Full Text] [Related]

  • 14. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
    Johansson J, Berg T, Kurzejamska E, Pang MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, Fuxe J.
    Oncogene; 2013 Dec 12; 32(50):5614-24. PubMed ID: 23955085
    [Abstract] [Full Text] [Related]

  • 15. Examining the role of cyclin D1 in breast cancer.
    Velasco-Velázquez MA, Li Z, Casimiro M, Loro E, Homsi N, Pestell RG.
    Future Oncol; 2011 Jun 12; 7(6):753-65. PubMed ID: 21675838
    [Abstract] [Full Text] [Related]

  • 16. CCAAT/enhancer binding protein β negatively regulates progesterone receptor expression in human glioblastoma cells.
    Hansberg-Pastor V, González-Arenas A, Camacho-Arroyo I.
    Mol Cell Endocrinol; 2017 Jan 05; 439():317-327. PubMed ID: 27663075
    [Abstract] [Full Text] [Related]

  • 17. The role of C/EBPbeta in mammary gland development and breast cancer.
    Grimm SL, Rosen JM.
    J Mammary Gland Biol Neoplasia; 2003 Apr 05; 8(2):191-204. PubMed ID: 14635794
    [Abstract] [Full Text] [Related]

  • 18. CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases.
    Zahnow CA.
    Expert Rev Mol Med; 2009 Apr 08; 11():e12. PubMed ID: 19351437
    [Abstract] [Full Text] [Related]

  • 19. 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C.
    Zheng R, Wang X, Studzinski GP.
    J Steroid Biochem Mol Biol; 2015 Apr 08; 148():132-7. PubMed ID: 25448741
    [Abstract] [Full Text] [Related]

  • 20. Deregulation of the endogenous C/EBPβ LIP isoform predisposes to tumorigenesis.
    Bégay V, Smink JJ, Loddenkemper C, Zimmermann K, Rudolph C, Scheller M, Steinemann D, Leser U, Schlegelberger B, Stein H, Leutz A.
    J Mol Med (Berl); 2015 Jan 08; 93(1):39-49. PubMed ID: 25401168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.